Modelling the adverse effects associated with ecstasy use

Addiction

Volumn 106, Issue 4, 2011, Pages 798-805

  Fisk, John E ^a   Murphy, Philip N ^b   Montgomery, Catharine ^c   Hadjiefthyvoulou, Florentia ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b EDGE HILL UNIVERSITY   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Adverse effects; Alcohol; Anxiety; Depression; Ecstasy; Mood

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PSYCHEDELIC AGENT; STREET DRUG;

ADDICTION; ADULT; AFFECT; ANXIETY; ARTICLE; ATTITUDE TO HEALTH; BINOMIAL DISTRIBUTION; CHEMICALLY INDUCED DISORDER; CONFUSION; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFECT; DRUG USE; FEMALE; HEALTH STATUS; HUMAN; MALE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SLEEP DISORDER;

AFFECT; ALCOHOL DRINKING; ANXIETY; BINOMIAL DISTRIBUTION; CONFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG USERS; FEMALE; HALLUCINOGENS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RISK FACTORS; SLEEP DISORDERS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 79952295918     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03272.x     Document Type: Article

References (41)

1. Parrott A. C., Buchanan T., Scholey A. B. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacol 2002; 17: 309-12.
2. Parrott A. C., Rodgers J., Buchanan T., Ling J., Heffernan T., Scholey A. B. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. Hum Psychopharmacol 2006; 21: 285-98.
3. Thomasius R., Petersen K., Buchert R., Andresen B., Zapletalova P., Wartberg L. etal. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 2003; 167: 85-96.
4. Parrott A. C., Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berl) 1998; 139: 261-8.
5. Curran H. V., Travill R. A. Mood and cognitive effects of ± 3, 4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): weekend 'high' followed by mid-week low. Addiction 1997; 92: 821-31.
6. 1-sup-5O]-positron emission tomography study. J Clin Psychopharmacol 2001; 21: 66-71.
7. McCardle K., Luebbers S., Carter J. D. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology (Berl) 2004; 173: 434-9.
8. Lamers C. T. J., Bechara A., Rizzo M., Ramaekers J. G. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. J Psychopharmacol 2006; 20: 302-11.
9. Thomasius R., Zapletalova P., Petersen K., Buchert R., Andresen B., Wartberg L. etal. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol 2006; 20: 211-25.
10. Curran H. V., Rees H., Hoare T. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology (Berl) 2004; 173: 425-33.
11. Hoshi R., Pratt H., Mehta S. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood-are there gender differences? J Psychopharmacol 2006; 20: 291-301.
12. Morgan M. J. Recreational use of 'ecstasy' (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 1998; 19: 252-64.
13. Dafters R. I., Duffy F., O'Donnell P. J. Level of use of 3, 4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence. Psychopharmacology (Berl) 1999; 145: 82-90.
14. Bedi G., Van Dam N. T., Redman J. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy use. J Psychopharmacol 2010; 24: 233-40.
15. Falck R. S., Wang J., Carlson R. G. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis. J Psychopharmacol 2008; 22: 47-54.
16. Fisk J. E., Montgomery C. Sleep impairment in ecstasy/polydrug and cannabis-only users. Am J Addict 2009; 18: 430-7.
17. Fisk J. E., Montgomery C., Murphy P. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users. Exp Clin Psychopharmacol 2009; 17: 326-36.
18. Fisk J. E., Montgomery C., Wareing M., Murphy P. The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic? Hum Psychopharmacol 2006; 21: 355-66.
19. Raven J., Raven J. C., Court J. H. Manual for Raven's Progressive Matrices and Vocabulary Scales. Oxford, UK: Oxford Psychologists Press; 1998.
20. Murphy P. N., Wareing M., Fisk J. E. Users' perceptions of the risks and effects of taking MDMA (Ecstasy). J Psychopharmacol 2006; 20: 447-55.
21. Craig L., Fisk J. E., Montgomery C., Murphy P. N., Wareing M. Is emotional intelligence impaired in ecstasy-polydrug users? J Psychopharmacol 2010; 24: 221-31.
22. Johns M., Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep 1997; 20: 844-9.
23. Johns M. W. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992; 15: 376-81.
24. Matthews G., Jones D. M., Chamberlain G. A. Refining the measurement of mood: the UWIST mood adjective checklist. Br J Psychol 1990; 81: 17-42.
25. Allison P. D. Fixed Effects Regression Methods for Longitudinal Data Using SAS, chapter 4. Cary, NC: SAS Institute Incorporated; 2005.
26. ® 9.2 user's Guide, chapter 51, 2nd edn. Cary, NC: SAS Institute Inc.; 2009.
27. Baylen C. A. A review of the acute subjective effects of MDMA/ecstasy. Addiction 2006; 101: 933-47.
28. Soar K., Turner J. J. D., Parrott A. C. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors. J Psychopharmacol 2006; 20: 417-24.
29. Rodgers J., Buchanan T., Pearson C., Parrott A. C., Ling J., Heffernan T. etal. Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study. J Psychopharmacol 2006; 20: 437-46.
30. Guillot C., Greenway D. Recreational ecstasy use and depression. J Psychopharmacol 2006; 20: 411-6.
31. Scott R. M., Hides L., Allen J., Burke R., Lubman D. I. Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use. Psychopharmacology (Berl) 2010; 209: 25-36.
32. Medina K. L., Shear P. K. Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use. Drug Alcohol Depend 2007; 87: 303-11.
33. Durdle H., Lundahl L. H., Johanson C.-E., Tancer M. Major depression: the relative contribution of gender, MDMA, and cannabis use. Depress Anxiety 2008; 25: 241-7.
34. de Win M. M. L., Schilt T., Reneman L., Vervaeke H., Jager G., Dijkink S. etal. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. J Psychopharmacol 2006; 20: 226-35.
35. Izco M., Orio L., O'Shea E., Colado M. I. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Psychopharmacology (Berl) 2007; 189: 459-70.
36. Cassel J.-C., Riegert C., Rutz S., Koenig J., Rothmaier K., Cosquer B. etal. Ethanol, 3, 4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. Neuropsychopharmacology 2005; 30: 1870-82.
37. Winstock A. R., Griffiths P., Stewart D. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 2001; 64: 9-17.
38. Rivas-Vazquez R. A., Delgado L. Clinical and toxic effects of MDMA ('Ecstasy'). Prof Psychol Res Pr 2002; 33: 422-5.
39. Schifano F., Di Furia L., Forza G., Minicuci N., Bricolo R. MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 1998; 52: 85-90.
40. Gouzoulis-Mayfrank E., Daumann J. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol 2006; 20: 188-93.
41. Scholey A. B., Parrott A. C., Buchanan T., Heffernan T. M., Ling J., Rodgers J. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addict Behav 2004; 29: 743-52.